LTBP2 is a prognostic marker in head and neck squamous cell carcinoma

Liang Han; Ming ming Tang; Xinjiang Xu; Bin Jiang; Jianfei Huang; Xingmei Feng; Jianfeng Qiang

doi:10.18632/oncotarget.8855

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

LTBP2 is a prognostic marker in head and neck squamous cell carcinoma

Liang Han, Ming ming Tang, Xinjiang Xu, Bin Jiang, Jianfei Huang, Xingmei Feng _ and Jianfeng Qiang

PDF | HTML | How to cite

Oncotarget. 2016; 7:45052-45059. https://doi.org/10.18632/oncotarget.8855

Metrics: PDF 2795 views | HTML 2586 views | ?

Abstract

Liang Han1, Ming Ming Tang1, Xinjiang Xu1, Bin Jiang1, Jianfei Huang2, Xingmei Feng3, Jianfeng Qiang4

1Department of Head and Neck Surgery, Affiliated Tumor Hospital of Nantong University, Nantong Tumor Hospital, Nantong, Jiangsu, China

2Department of Clinical Pathology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China

3Department of Stomatology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China

4Department of Graduate, Medical School of Nantong University, Nantong, Jiangsu, China

Correspondence to:

Xingmei Feng, email: [email protected]

Jianfeng Qiang, email: [email protected]

Keywords: head and neck squamous cell carcinoma, qPCR, immunohistochemistry, LTBP2, prognosis

Received: January 09, 2016 Accepted: April 02, 2016 Published: April 20, 2016

ABSTRACT

Latent transforming growth factor (TGF)-beta binding protein 2 (LTBP2) belongs to the fibrillin/LTBP extracellular matrix glycoprotein superfamily. It plays vital roles in tumorigenesis through regulating TGFβ activity, elastogenesis and maintenance of the extracellular matrix (ECM) structure. In this study, we determined the expression levels of LTBP2 mRNA and protein in head and neck squamous cell carcinoma (HNSCC) tissues and adjacent normal tissues by quantitative reverse transcription PCR (qRT-PCR) and tissue microarray immunohistochemistry analysis (TMA-IHC) respectively. LTBP2 protein levels in cancer tissues were correlated with HNSCC patients’ clinical characteristics and overall survival. Both LTBP2 mRNA and protein levels were significantly higher in HNSCC tissues than in adjacent normal tissues. High LTBP2 protein level was associated with lymph node metastasis and higher pTNM stages. High LTBP2 protein level is an independent prognostic marker in HNSCC. Our data suggest that LTBP2 acts as an oncogene in HNSCC development and progression. Detection of LTBP2 expression could be a useful prognosis marker and targeting LTBP2 may represent a novel strategy for cancer treatment through regulating activities of TGFβ.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 8855

Publication Alerts

Post-Publication Promotion

Research Papers:

LTBP2 is a prognostic marker in head and neck squamous cell carcinoma

Abstract